AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 67 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,700 | +24.6% | 5,000 | 0.0% | 0.00% | – |
Q2 2023 | $4,575 | +63.3% | 5,000 | 0.0% | 0.00% | – |
Q1 2023 | $2,802 | -2.9% | 5,000 | 0.0% | 0.00% | – |
Q4 2022 | $2,885 | +44.2% | 5,000 | 0.0% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 5,000 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | -50.0% | 5,000 | 0.0% | 0.00% | – |
Q1 2022 | $4,000 | -50.0% | 5,000 | +412.8% | 0.00% | -100.0% |
Q1 2019 | $8,000 | +60.0% | 975 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $5,000 | -44.4% | 975 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $9,000 | -10.0% | 975 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $10,000 | +11.1% | 975 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $9,000 | – | 975 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |